Emerging Developments in Corporate Governance, Impact of COVID-19, and Looking Ahead to 2022February 2, 2022
OIG Issues Favorable Advisory Opinion on Retailer’s Proposed Expansion of Discount Programs for Low-Income IndividualsFebruary 2, 2022
Pharmacy Pays Over $2 Million for Allegedly Billing Government to Switch Patients to More Expensive MedicationsFebruary 2, 2022
Fourth Circuit Applies Safeco to FCA Claims, Accuses CMS of “Maintaining Strategic Ambiguity” Around Medicaid Drug Rebate Program RequirementsFebruary 1, 2022
Fourth Circuit: Safeco Defense Applies to FCA Claims and Dooms Medicaid Best Price Qui TamFebruary 1, 2022
First Circuit Adopts Deferential Standard for Review of Government Decisions to Dismiss FCA Whistleblower CasesFebruary 1, 2022
New Whistleblowing Laws in Europe Are Generating Additional Homework for Companies’ Compliance EffortsFebruary 1, 2022
Recent Resolution of Fraud Allegations Signals DOJ’s Increased Use of Corporate MonitorshipsJanuary 31, 2022
Pharmacy Executive Pleads Guilty to Defrauding DoD, VA for $88 Million with Overpriced DrugsJanuary 31, 2022
Texas Doctors and Hospital Exec to Pay Over $1.1 Million to Settle Alleged Kickback and Stark ViolationsJanuary 31, 2022
Fourth Circuit Adopts Safeco’s Objective Reasonableness Standard for False Claims ActJanuary 28, 2022
Task Force Solicits Comments on Implementation of Import Ban on Forced-Labor Goods from ChinaJanuary 28, 2022
